Holdings
Eversept Partners, LP
As of Jun 30, 2026, Eversept Partners, LP reported 104 positions worth US$1.77B. Largest: United Therapeutics Corporation, Abivax Sa and Encompass Health Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| United Therapeutics Corporation | 288K | US$156M | +23,397 | Jun 30, 2026 |
| Abivax Sa | 914K | US$122M | −20,543 | Jun 30, 2026 |
| Encompass Health Corporation | 1.03M | US$104M | +833K | Jun 30, 2026 |
| The Ensign Group, Inc. | 602K | US$96.5M | +587K | Jun 30, 2026 |
| Vera Therapeutics, Inc. | 2.21M | US$94.9M | +39,484 | Jun 30, 2026 |
| Celldex Therapeutics, Inc. | 1.79M | US$66.5M | −2,075 | Jun 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 2.8M | US$61.2M | −87,412 | Jun 30, 2026 |
| Brookdale Senior Living Inc. | 3.4M | US$54.6M | −172K | Jun 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 665K | US$52.7M | +32,584 | Jun 30, 2026 |
| Natera, Inc. | 176K | US$47.7M | −209K | Jun 30, 2026 |